Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Martin Swaans , Ben van den Branden , Marco Post , et al Added: 3 years ago
In Europe, mitral regurgitation (MR) is the second most common form of valvular heart disease needing surgery.1 Studies have shown that up to 50 % of patients with severe symptomatic MR are not referred to surgery, even if a surgical indication exists.1–3 Reasons for denying surgery include impaired left ventricular ejection fraction, a high operative risk, multiple comorbidities or advanced age… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Author(s): Mehmet Ali Elbey , Luis Augusto Palma Dallan , Guilherme Ferragut Attizzani Added: 3 years ago
The field of mitral valve disease diagnosis and management is in constant change. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities have led to more complex treatments. Transcatheter mitral valve repair with a MitraClip device is resulting in good outcomes in patients with primary mitral regurgitation who are at high… View more

Vascular Disease and Surgery

Intervention
Job title: Interventional Cardiologist
Dr Tomás Benito González is an interventional cardiologistat theUniversity Hospital of León, ES. His research interests are centred around ground-breaking areas such as percutaneous Mitral Valve Repair, percutaneous left atrial appendage closure, and the implications of Mitral Valve repair with Mitraclip, making significant contributions to the ongoing evolution of cardiac care. View more
Dr Ander Regueiro is a highly accomplished cardiologist with over a decade of experience. Dr Ander Regueiro obtained his Bachelor in Medicine from Universidad Autónoma de Querétaro in 2006, followed by specialty training in Cardiology at Hospital Clinic de Barcelona, Universitat de Barcelona. Dr Ander Regueiro holds multiple Master's degrees, including Clinical Research and Advanced Medical… View more
ESC 2019 - MITRA-FR - Prof Jean-François Obadia
Author(s): Jean-François Obadia Added: 4 years ago
Prof Jean-François Obadia (Civils Hospices of Lyon, FR) discusses 2-year follow-up of the MITRA-FR study: A randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation. Filmed on site at ESC 2019 by Radcliffe Cardiology. View more

Heart Failure

Intervention
Research Area(s) / Expertise:
Dr Martin Swaans is cardiologist at St Antonius Hospital Nieuwegein in the Netherlands. Dr Swaans specialises in cardiac imaging, particularly in electrophysiology and interventional procedures. He is a frequent speaker at conferences around the globe and a world authority for interventional imaging. DrSwaans is heavily involved in the development of cutting edge imaging technologies. View more
Author(s): Lazar Mandinov , Karl-Heinz Kuck , Eberhard Grube Added: 3 years ago
Functional mitral regurgitation (FMR) is a common complication after myocardial infarction and results from significant left ventricle (LV) remodelling with annulus dilatation and papillary muscle displacement causing tethering and incomplete coaptation of the leaflets.1,2 Surgical management of FMR has consisted of mitral valve repair with suture, band or ring annuloplasty, or mitral valve… View more

Vascular Disease and Surgery

Intervention
Author(s): Kimberly Atianzar , Ming Zhang , Zachary Newhart , et al Added: 3 years ago
In patients with heart failure and reduced left ventricular ejection fraction (LVEF), secondary (functional) mitral regurgitation, in which the mitral valve leaflets and chordae are essentially normal, is the result of functional and structural alterations of the left ventricle (LV). Severe secondary mitral regurgitation (MR) is a predictor of poor clinical outcomes in this patient population due… View more

Heart Failure

Intervention
Author(s): Kelly H Schlendorf , Jared O’Leary , JoAnn Lindenfeld Added: 3 years ago
Mitral regurgitation (MR) is common in industrialized countries, with a prevalence of about 2% in the general population and about 9% in people over 75 years old.1,2 MR is classified as primary/degenerative when it results from a structural abnormality of the valve apparatus, or secondary/functional when it results from a disturbance of ventricular or annular geometry and/or function that impairs… View more

Vascular Disease and Surgery

Heart Failure